Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection.
about
Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Prevalence and impact of basel ...... vir against GT1 HCV infection.
@en
Prevalence and impact of basel ...... vir against GT1 HCV infection.
@nl
type
label
Prevalence and impact of basel ...... vir against GT1 HCV infection.
@en
Prevalence and impact of basel ...... vir against GT1 HCV infection.
@nl
prefLabel
Prevalence and impact of basel ...... vir against GT1 HCV infection.
@en
Prevalence and impact of basel ...... vir against GT1 HCV infection.
@nl
P2093
P2860
P1433
P1476
Prevalence and impact of basel ...... vir against GT1 HCV infection.
@en
P2093
Alexander Kuo
Ananthakrishnan Ramani
David R Nelson
Gary P Wang
Giuseppe Morelli
Jacqueline D Reeves
Joseph K Lim
Josh Levitsky
P2860
P356
10.1038/S41598-018-21303-2
P407
P577
2018-02-16T00:00:00Z